| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/15/2004 | DE10000046B4 Vorrichtung zur Anzeige der Zeitdauer des Aufbrühens von Teegetränken A device for indicating the time duration of the brewing of tea beverages |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2493860A1 Marker genes for determining renal toxicity |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2492040A1 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/15/2004 | CA2492010A1 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | CA2492005A1 A method of assaying the antioxidant activity of pure compounds, extracts and biological fluids |
| 01/15/2004 | CA2491947A1 The use of specified tcf target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which tcf/.beta.-catenin/wnt signalling plays a central role |
| 01/15/2004 | CA2491896A1 Monitoring of cells |
| 01/15/2004 | CA2491691A1 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 01/15/2004 | CA2491687A1 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | CA2491637A1 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | CA2491618A1 Microarrays on mirrored substrates for performing proteomic analyses |
| 01/15/2004 | CA2491488A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2004 | CA2491471A1 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 01/15/2004 | CA2491417A1 Method for screening an agent for improving insulin resistance |
| 01/15/2004 | CA2491407A1 Serological diagnostic method |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491017A1 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | CA2490903A1 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 01/15/2004 | CA2490572A1 Pig binding protein from adipocytes |
| 01/15/2004 | CA2489588A1 Compositions and methods for the treatment of immune related diseases |
| 01/15/2004 | CA2489562A1 Mitotic kinesin binding site |
| 01/15/2004 | CA2489151A1 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 01/15/2004 | CA2487856A1 Methods for identification of compounds modulating insulin resistance |
| 01/14/2004 | EP1380844A2 Heater assembly for temperature and delivery control of liquids |
| 01/14/2004 | EP1380843A2 Automated liquid level sensing device |
| 01/14/2004 | EP1380842A2 Test sample container assembly |
| 01/14/2004 | EP1380840A1 Method of diagnosing breast cancer |
| 01/14/2004 | EP1380839A1 Production of spatially defined solid phases for binding assays |
| 01/14/2004 | EP1380838A2 Method of gas analysis for determining the reaction of a biological system |
| 01/14/2004 | EP1380837A1 Electrochemical test strip having a plurality of reaction chambers |
| 01/14/2004 | EP1380833A2 Apparatus for spectrometrically measuring isotopic gas |
| 01/14/2004 | EP1380831A2 Apparatus for measuring the breathability and comfort of a shoe |
| 01/14/2004 | EP1380830A2 Method and apparatus for detecting cracks in honeycomb structure |
| 01/14/2004 | EP1380829A1 Instrument for use in collecting and recovering liquid secretion in oral cavity |
| 01/14/2004 | EP1380810A1 Gauge calibration method |
| 01/14/2004 | EP1380653A1 Method of assaying lupus anticoagulant and assay reagent |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380648A2 Recombinant DNAase B derived from streptococcus pyogenes |
| 01/14/2004 | EP1380645A2 Production in bacteria ad yeast of hemoglobin and analogues thereof |
| 01/14/2004 | EP1380644A1 The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/14/2004 | EP1380632A1 Pyrazinoporphyrazines |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380338A2 Method for producing a microarray |
| 01/14/2004 | EP1380290A1 Cross-beta structure pathway and its therapeutic relevance |
| 01/14/2004 | EP1380258A2 Breath sampling bag and gas measuring apparatus |
| 01/14/2004 | EP1380205A1 Experimental animals for evaluation of therapeutic effects on corneal epithelial damages |
| 01/14/2004 | EP1380005A1 Computer method for image pattern recognition in organic material |
| 01/14/2004 | EP1380001A2 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 01/14/2004 | EP1379997A2 Predicting metabolic stability of drug molecules |
| 01/14/2004 | EP1379995A2 Automated information processing in randomly ordered arrays |
| 01/14/2004 | EP1379886A2 Method and device for measuring the acidity or basicity of insulating fluids, particularly mineral and synthetic oils |
| 01/14/2004 | EP1379885A2 Contrast enhancement agent for magnetic resonance imaging |
| 01/14/2004 | EP1379882A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders |
| 01/14/2004 | EP1379880A2 Screening for drugs against disorders associated with schizophrenia |
| 01/14/2004 | EP1379879A2 Diagnosis and treatment of alzheimer's disease |
| 01/14/2004 | EP1379878A2 Affinity selection-based screening of hydrophobic proteins |
| 01/14/2004 | EP1379877A2 Method for assaying protein nitrosylation |
| 01/14/2004 | EP1379876A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase |
| 01/14/2004 | EP1379875A1 Detection of biological pathway components |
| 01/14/2004 | EP1379874A1 Phycoerythrin labeled thyronine analogues and assays using the labeled analogues |
| 01/14/2004 | EP1379873A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 01/14/2004 | EP1379872A2 Use of metabolic phenotyping in individualized treatment with amonafide |
| 01/14/2004 | EP1379871A2 Methods and means for determining fitness in plants |
| 01/14/2004 | EP1379870A1 A crystal of bacterial core rna polymerase with rifampicin and methods of use thereof |
| 01/14/2004 | EP1379868A2 Transgenic zebrafish models for neurodegenerative diseases |
| 01/14/2004 | EP1379860A1 Apparatus and method for analysing fluids |
| 01/14/2004 | EP1379856A2 Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |
| 01/14/2004 | EP1379854A2 Method and device for measuring blanks |
| 01/14/2004 | EP1379699A2 Detection of fungal pathogens using the polymerase chain reaction |
| 01/14/2004 | EP1379698A1 Mobility-modified nucleobase polymers and methods of using same |
| 01/14/2004 | EP1379697A1 Diagnostic detection of nucleic acids |
| 01/14/2004 | EP1379696A2 Prognostic methods for breast cancer |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379694A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 01/14/2004 | EP1379692A1 Nucleic acid analysis using non-templated nucleotide addition |
| 01/14/2004 | EP1379691A1 Differentially methylated sequences in pancreatic cancer |
| 01/14/2004 | EP1379685A2 Assay for the detection and quantitation of hemimethylation |
| 01/14/2004 | EP1379684A2 Method and system for detecting nucleic acids |
| 01/14/2004 | EP1379682A1 Cell isolation method and uses thereof |
| 01/14/2004 | EP1379681A2 Diagnosis by sensing volatile components |
| 01/14/2004 | EP1379679A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 01/14/2004 | EP1379678A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379660A2 Self-replicating rna molecule from hepatitis c virus |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379646A2 Engineered chimera of protein fragments and methods of use thereof |
| 01/14/2004 | EP1379644A2 Protein analysis by means of immobilized arrays of antigens or antibodies |
| 01/14/2004 | EP1379642A2 Arrayed transfection method and uses related thereto |
| 01/14/2004 | EP1379641A2 Process for the production and purification of secreted proteins and the production of arrays of proteins |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379634A1 Active site inactivators |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |